Use of griffithsin in preparing drugs for infection by novel coronaviruses
The present invention discloses a use of griffithsin in preparing drugs, the drugs are used for preventing and/or treating infection by coronaviruses, and the griffithsin comprises a sequence shown asSEQ ID NO.1 or an insertion, deletion/replacement functional variant of the sequence; and the coronaviruses comprises a novel coronavirus (SARS-CoV-2)..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 29. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
JIANG SHIBO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN112138160 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011482028 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011482028 | ||
| 003 | DE-627 | ||
| 005 | 20230504090811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210601s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011482028 | ||
| 035 | |a (EPA)CN112138160 | ||
| 035 | |a (EPA)73887687 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a JIANG SHIBO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of griffithsin in preparing drugs for infection by novel coronaviruses |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 | ||
| 520 | |a The present invention discloses a use of griffithsin in preparing drugs, the drugs are used for preventing and/or treating infection by coronaviruses, and the griffithsin comprises a sequence shown asSEQ ID NO.1 or an insertion, deletion/replacement functional variant of the sequence; and the coronaviruses comprises a novel coronavirus (SARS-CoV-2). | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LU LU |4 aut | |
| 700 | 0 | |a CAI YANXING |4 aut | |
| 700 | 0 | |a XU WEI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 29. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:29 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/73887687/publication/CN112138160A1?q=CN112138160 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 29 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 29 |c 12 | ||